Integrating pre- and post-treatment Plasma Epstein-Barr Virus DNA levels for better prognostic prediction of Nasopharyngeal Carcinoma

Background: Pre- and post-treatment plasma Epstein‐Barr virus (EBV) DNA are important biomarkers for the prognosis of nasopharyngeal carcinoma (NPC). This study was performed to determine the prognostic potential of integrating EBV DNA levels in plasma measured pre-treatment (pre-EBV) and 3 months p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cancer
Main Authors: Li, Wanxia, Yang, Chao, Lv, Zehong, Li, Junzheng, Li, Zonghua, Yuan, Xiaofei, Wu, Shuting, Yuan, Yue, Cui, Linchong, Lu, Juan, Chen, Jing, Zhao, Feipeng
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2021
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040726/
https://ncbi.nlm.nih.gov/pubmed/33854631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.56397
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares